SCHEMBL7265162

SCHEMBL7265162

COc1cc(OC)cc(C2=C3C=CC(=N3)C(c3cc(OC)cc(OC)c3)=C3C=CC(=N3)C(c3cc(OC)cc(OC)c3)=C3C=CC(=N3)C(c3ccc(NC(C)=O)cc3)=C3C=CC2=N3)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MTNR1A P48039 3/20 0.46
▸ MTNR1B P49286 3/20 0.46
▸ ADORA3 P0DMS8 2/20 0.43
▸ FGFR3 P22607 1/20 0.43
▸ HTT P42858 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ DYRK1A Q13627 1/20 0.40
▸ DYRK1B Q9Y463 1/20 0.40
▸ DDR2 Q16832 1/20 0.40
▸ ALK Q9UM73 1/20 0.40
▸ SLC2A1 P11166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10568742 0.87 SMN1; SMN2 (0.56) SMN1; SMN2HTTL3MBTL1KDM4EALDH1A1
SCHEMBL7241026 0.81 TSHR (0.49) SMN1; SMN2HTTL3MBTL1KDM4EALDH1A1
SCHEMBL7258049 0.80 MAPT (0.40) SMN1; SMN2LMNAMTNR1AMTNR1BADORA3
SCHEMBL498496 0.80 CYP1B1 (0.42) SMN1; SMN2KDM4EALDH1A1MAPTHPGD
SCHEMBL7261654 0.78 CYP19A1 (0.41) SMN1; SMN2LMNAKDM4EALDH1A1MAPT
SCHEMBL1974249 0.76 TDP1 (0.49) SMN1; SMN2LMNAHTTL3MBTL1KDM4E
SCHEMBL7239834 0.76 NPC1 (0.52) SMN1; SMN2HTTL3MBTL1KDM4EALDH1A1
SCHEMBL8865142 0.74 NPC1 (0.50) SMN1; SMN2KDM4EALDH1A1MAPTMEN1
SCHEMBL7241348 0.74 KMT2A (0.45) SMN1; SMN2HTTKDM4EALDH1A1MAPT
SCHEMBL1680192 0.73 ME2 (0.43) SMN1; SMN2LMNAADORA3L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203888-A1 Chromophores WELLCOME TRUST LIMITED, THE (GB) 2003-10-30 — — US disclosed
US-6419897-B1 PORPHYRIN COMPOUNDS ARIZONA BOARD OF REGENTS 2002-07-16 — — US disclosed
US-6274729-B1 PREVENT TISSUE DAMAGE ARIZONA BOARD OF REGENTS 2001-08-14 — — US disclosed
US-6207821-B1 Long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis ARIZONA BOARD OF REGENTS 2001-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203888-A1 Chromophores HCCS, PPOX, HMBS SMN1; SMN2 4747/4885LMNA 2646/4885MTNR1A 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback